Mariette van der Velden-Roesink

Mariette van der Velden-Roesink is a distinguished professional in the biotechnology and private equity sectors, serving as a Board Observer for multiple companies including TargED Biopharmaceuticals, Flindr Therapeutics, and Citryll since 2022. As a Founding Partner at Curie Capital BV and an Owner of Curiant BV, Mariette has significant entrepreneurial experience. Additional leadership roles include positions on the Supervisory Boards of Cleara Biotech and previously Allero Therapeutics. With a strong educational background that includes a Master’s degree in Medical Biology from Vrije Universiteit Amsterdam and certifications in Private Equity and Investment Management, Mariette combines extensive expertise in both scientific and business environments. Member of the board at Roesink Verpakkingsmachines BV since 1997, Mariette continues to contribute to various ventures in the life sciences.